Risk factors for recurrence after Staphylococcus aureus bacteraemia. A retrospective matched case–control study

Walker, Timothy M; Bowler, I.C.J.W.; Bejon, Philip

doi:10.1016/j.jinf.2009.03.011

Cited by 33 publications

(19 citation statements)

References 14 publications

(11 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…24 This has been attributed to improvements in infection control and insertion 37 Moreover, guidelines and studies have shown that recurrence of infection will likely occur if an infected CVC is not removed. 38 All central line catheters were removed in each documented case of S aureus CLABSI that we retrospectively reviewed. In the future, it would be interesting to conduct a cohort study that prospectively follows patients after central line insertions at our institution.…”

Section: Discussionmentioning

confidence: 99%

Epidemiology of bloodstream infections caused by methicillin-resistant Staphylococcus aureus at a tertiary care hospital in New York

Yasmin

Hage

Obeid

et al. 2016

American Journal of Infection Control

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Epidemiology of bloodstream infections caused by methicillin-resistant Staphylococcus aureus at a tertiary care hospital in New York

Yasmin

Hage

Obeid

et al. 2016

American Journal of Infection Control

View full text Add to dashboard Cite

“…There are several observational studies regarding the duration of therapy for S. aureus bacteremia, which usually focused on the management of CRBSI or the recurrence of S. aureus bacteremia (4)(5)(6)(7)(8)(25)(26)(27)(28)(29)(30). In these studies, patients had diverse clinical characteristics of S. aureus bacteremia with various extents and severities of infection.…”

Section: Discussionmentioning

confidence: 99%

Treatment Duration for Uncomplicated Staphylococcus aureus Bacteremia To Prevent Relapse: Analysis of a Prospective Observational Cohort Study

Chong

Moon

Bang

et al. 2013

Antimicrob Agents Chemother

108

View full text Add to dashboard Cite

In multivariate analysis, primary bacteremia was associated with a trend toward increased treatment failure (P ‫؍‬ 0.06). Therefore, in the treatment of uncomplicated SAB, it seems reasonable to consider at least 14 days of antibiotic therapy to prevent relapse, as practice guidelines recommend. Because of its poor prognosis, primary bacteremia, even with a low risk of complication, should not be treated with short-course therapy.

show abstract

“…The type of vascular access itself maybe a major factor, as both a primary source of bacteraemia [7][8][9][10][11] or as a potential influence on the outcome of another infective episode [4,5,12]. For example, a venous catheter may act as the portal for the direct entry of organisms into the circulation, via either the exit site on the skin or catheter lumen.…”

Section: Discussionmentioning

confidence: 99%

Chapter 12: Epidemiology of Methicillin Resistant Staphylococcus Aureus Bacteraemia Amongst Patients Receiving Dialysis for Established Renal Failure in England in 2008: a joint report from the UK Renal Registry and the Health Protection Agency

Fluck

Wilson²,

Tomson

2010

Nephron Clin Pract

View full text Add to dashboard Cite

Background: From April 2007, all centres providing renal replacement therapy in England were asked to provide additional data on patients with Methicillin Resistant Staphylococcus aureus (MRSA) bacteraemia using a secure web based system established to capture data for the mandatory surveillance of MRSA bacteramia. Results: From April 2008 until March 2009 171 discrete episodes of MRSA bacteraemia were identified from the Health Protection Agency database as being potentially associated with patients in established renal failure (ERF) requiring dialysis. Of 171 records, 18 records were rejected by renal centres as not being associated with patients on dialysis or as being duplicates of other records. Following data validation by centres, 139 patients had vascular access documented (no episodes of bacteraemia were recorded amongst patients receiving peritoneal dialysis). Of these patients, 30.2% were utilising an arteriovenous fistula or graft and 69.8% were dialysing on a nontunnelled or tunnelled venous catheter. Two of the patients on arteriovenous fistulae had used venous catheters in the prior 28 days. Eleven patients had more than one episode in the year and accounted for 30 (20%) of the episodes of MRSA bacteraemia. Overall there was a reduction of 22% in episodes from the previous year. The median centre-specific rate of MRSA bacteraemia was 0.64 (range 0–3.49) episodes per 100 haemodialysis patients per year, and 0.55 (range 0–2.89) episodes per 100 dialysis (haemodialysis and peritoneal dialysis combined) patients per year. Conclusions: The rate of MRSA bacteraemia in patients requiring long term dialysis continues to fall within the prevalent dialysis population in England, but there is still marked variation in centrespecific rates.

show abstract

Risk factors for recurrence after Staphylococcus aureus bacteraemia. A retrospective matched case–control study

Cited by 33 publications

References 14 publications

Epidemiology of bloodstream infections caused by methicillin-resistant Staphylococcus aureus at a tertiary care hospital in New York

Epidemiology of bloodstream infections caused by methicillin-resistant Staphylococcus aureus at a tertiary care hospital in New York

Treatment Duration for Uncomplicated Staphylococcus aureus Bacteremia To Prevent Relapse: Analysis of a Prospective Observational Cohort Study

Chapter 12: Epidemiology of Methicillin Resistant Staphylococcus Aureus Bacteraemia Amongst Patients Receiving Dialysis for Established Renal Failure in England in 2008: a joint report from the UK Renal Registry and the Health Protection Agency

Contact Info

Product

Resources

About